echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Stroke: Endovascular therapy, is there a difference between black and white Americans?

    Stroke: Endovascular therapy, is there a difference between black and white Americans?

    • Last Update: 2022-03-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Endovascular therapy (EVT) is a highly impactful treatment for selected patients with acute ischemic stroke
    (AIS) with large vessel occlusion (LVO) .

    Vascular stroke

    However, effective screening and implementation of EVT relies on professional competence, not every hospital caring for AIS patients can do it
    .


    In a previous study examining selected hospital subgroups, black patients were less likely to receive intravenous recombinant tissue-type plasma protein activator (IV tPA) and EVT compared with white patients


    screening

    To assess this question more completely, Youngran Kim et al.
    of Harvard University used a full-sample dataset that captured all patients treated during the study period across the state, regardless of hospital type
    .


    They examined access to and utilization of EVT for AIS by ethnicity and validated their findings in an independent national sample


    They conducted a retrospective, population-based study using the 2019 Texas Inpatient Public Use Data File
    .


    Acute ischemic stroke cases and EVT use were determined using diagnostic and procedural codes from the International Classification of Diseases, tenth revision (ICD-10)


    diagnosis

    They examined EVT use by race/ethnicity and performed patient- and hospital-level analyses
    .


    To validate the state-by-state findings, a patient-level analysis was performed using the 2017 national sample of hospitalized patients to obtain national estimates


    Of the 40,814 acute ischemic stroke cases in Texas in 2019, 54% were white, 17% were black, and 21% were Hispanic
    .


    Black patients had similar EVT performance hospital admissions and more comprehensive stroke centers (CSCs) compared with white patients (EVT 62% vs 62%, P=0.


     

    EVT rates did not differ between Hispanic and white patients
    .


    The lower EVT rate among black patients was consistent in the subgroup who arrived at an early time window and received intravenous recombinant tissue-type plasma protein activator (adjusted relative risk, 0.


    Data from a nationwide sample confirmed the finding that black patients had less EVT use (adjusted relative risk, 0.
    87 [0.
    77-0.
    98], P=0.
    024)
    .

    Nationwide sample data corroborates finding that black patients utilize less EVT

    The significance of this study lies in its findings: There were no differences in visits to hospitals or CSCs where EVT was performed; however, EVT use was lower in black patients
    .

    There were no differences in visits to hospitals or CSCs where EVT was performed; however, EVT use was lower in black patients
    .



    Original source:
    Kim Y, Sharrief A, Kwak MJ, et al.


    Underutilization of Endovascular Therapy in Black Patients With Ischemic Stroke: An Analysis of State and Nationwide Cohorts.
    Stroke.


    Underutilization of Endovascular Therapy in Black Patients With Ischemic Stroke: An Analysis of State and Nationwide Cohorts.
    Stroke.
    Leave a Comment
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.